AXGN Axogen Inc.

Axogen, Inc. to Report Third Quarter 2020 Financial Results and Host Conference Call on October 29, 2020

Axogen, Inc. to Report Third Quarter 2020 Financial Results and Host Conference Call on October 29, 2020
EN
08/10/2020

Underlying

AXGNAxogen Inc.

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Axogen Inc.

 PRESS RELEASE
Free
AXGN AXOGEN INC.

Axogen, Inc. to Participate in Multiple Upcoming Investor Conferences

Axogen, Inc. to Participate in Multiple Upcoming Investor Conferences ALACHUA, Fla. and TAMPA, Fla., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for the restoration of peripheral nerve function, today announced that management is scheduled to participate in four upcoming investor conferences: Cantor Global Healthcare Conference (NYC)Participation: Fireside chat and 1x1 investor meetings Date/Time: Fireside Chat Wednesday, September 3, 2025, 3:20 PM ETWebcast Link: Wells Fargo Healthcare Confere...

August 27, 2025 1 EN
 PRESS RELEASE
Free
AXGN AXOGEN INC.

Axogen Provides Update on FDA Review Timeline for Avance Nerve Graft

Axogen Provides Update on FDA Review Timeline for Avance Nerve Graft FDA PDUFA goal date extended by three months ALACHUA, Fla. and TAMPA, Fla., Aug. 25, 2025 (GLOBE NEWSWIRE) -- Axogen, Inc. (Nasdaq: AXGN) today announced that the U.S. Food and Drug Administration (FDA) has extended the Prescription Drug User Fee Act (PDUFA) goal date for its Biologics License Application (BLA) for Avance® Nerve Graft by three months to December 5, 2025. On August 22, 2025, the Company received a communication from the FDA indicating that the information submitted by the Company in response to an FD...

August 25, 2025 1 EN
 PRESS RELEASE
Free
AXGN AXOGEN INC.

Axogen, Inc. Reports Second Quarter 2025 Financial Results

Axogen, Inc. Reports Second Quarter 2025 Financial Results Raises Full Year Revenue Guidance to at Least 17% Growth or $219 Million ALACHUA, Fla. and TAMPA, Fla., Aug. 05, 2025 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for the restoration of peripheral nerve function, today reported financial results and business highlights for the second quarter ended June 30, 2025. Second Quarter Financial Results Second quarter revenue was $56.7 million, an 18.3% increase compared to the second quarter of 2024,...

August 5, 2025 1 EN
 PRESS RELEASE
Free
AXGN AXOGEN INC.

Axogen, Inc. to participate at the Canaccord Genuity 45th Annual Growt...

Axogen, Inc. to participate at the Canaccord Genuity 45th Annual Growth Conference ALACHUA, Fla. and TAMPA, Fla., July 29, 2025 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for the restoration of peripheral nerve function, today announced that management will be available for one-on-one investor meetings at the Canaccord Genuity 45th Annual Growth Conference on Tuesday, August 12, 2025. About Axogen Axogen (AXGN) is the leading Company focused specifically on the science, development, and commercialization of ...

July 29, 2025 1 EN
 PRESS RELEASE
Free
AXGN AXOGEN INC.

Axogen, Inc. to report 2025 second quarter financial results on August...

Axogen, Inc. to report 2025 second quarter financial results on August 5, 2025 ALACHUA, Fla. and TAMPA, Fla., July 22, 2025 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for the restoration of peripheral nerve function, today announced that it will report 2025 second quarter financial results on Tuesday, August 5, 2025, before the market opens. Axogen management will host an investment-community conference call and webcast at 8 a.m. ET following the release. Investors interested in participating in the conferenc...

July 22, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch